Biotech firm Windtree Therapeutics has announced plans to purchase up to $700 million worth of BNB, following the cryptocurrency hitting an all-time high price. The company, which trades on the Nasdaq, is raising funds to support this acquisition. Initially, Windtree aimed to buy $200 million worth of BNB and has since increased its commitment to a total of $700 million, leveraging a $500 million equity line of credit and a $20 million stock-purchase agreement. Windtree's CEO positioned this strategy as critical for their financial growth as they partner with crypto exchange Kraken for asset custody. BNB, currently the fifth-largest cryptocurrency with a market cap of $106.9 billion, experienced a surge past its previous high of $808. This trend reflects a broader movement among public companies to build crypto treasuries to enhance their financial portfolios, similar to initiatives undertaken by other organizations in the tech and finance sectors.

Source 🔗